AMP challenges at 12 hourly intervals do not induce tachyphylaxis in mild asthmatic patients
J. A. Fairwood, S. J. Langley, A. Hussain, R. D. Murdoch, A. Weeks, P. Russell, A. A. Woodcock, D. Singh (Manchester, Greenford, United Kingdom)
Source: Annual Congress 2005 - Monitoring response to treatment in asthma and COPD
Session: Monitoring response to treatment in asthma and COPD
Session type: Thematic Poster Session
Number: 3688
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. A. Fairwood, S. J. Langley, A. Hussain, R. D. Murdoch, A. Weeks, P. Russell, A. A. Woodcock, D. Singh (Manchester, Greenford, United Kingdom). AMP challenges at 12 hourly intervals do not induce tachyphylaxis in mild asthmatic patients. Eur Respir J 2005; 26: Suppl. 49, 3688
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
ΔFVC% at PC20 AMP is negatively correlated with response to 6 weeks fluticasone treatment in asthma Source: Eur Respir J 2002; 20: Suppl. 38, 411s Year: 2002
The bronchoprotective effects of levocetirizine on adenosine monophosphate challenge in patients with atopic asthma Source: Eur Respir J 2004; 24: Suppl. 48, 220s Year: 2004
Evidence of a refractory period following airway narrowing and spontaneous recovery to inhaled mannitol in a proportion of asthmatics Source: Eur Respir J 2005; 26: Suppl. 49, 371s Year: 2005
Inhaled AMP induces a systemic inflammatory response in mild asthmatics Source: Eur Respir J 2003; 22: Suppl. 45, 350s Year: 2003
Mild asthmatic patients consistently respond to natural, low dose, allergen challenge in an EEC Source: Annual Congress 2011 - Diagnosis and treatment of inflammatory respiratory diseases Year: 2011
Subjects in clinical remission of atopic asthma show normal dyspnoea perception during methacholine and adenosine induced bronchoconstriction Source: Eur Respir J 2001; 18: Suppl. 33, 46s Year: 2001
The effect of single dose inhaled budesonide on Amppc20 in patients with mild asthma: a 3 month follow up Source: Eur Respir J 2005; 26: Suppl. 49, 369s Year: 2005
Effect of an inhaled alpha4-antagonist on the allergen-induced late asthmatic response in patients with mild asthma Source: Eur Respir J 2005; 26: Suppl. 49, 135s Year: 2005
Effects of salmeterol, formoterol and placebo on pulmonary function and symptom recovery after histamine provocation in mild asthmatics Source: Eur Respir J 2004; 24: Suppl. 48, 710s Year: 2004
Effects of regular formoterol treatment on airway hyperresponsiveness in patients with mild to moderate asthma Source: Eur Respir J 2003; 22: Suppl. 45, 285s Year: 2003
Effect of antileukotriene therapy on methacholine challenge test in patients with mild asthma Source: Eur Respir J 2004; 24: Suppl. 48, 587s Year: 2004
Functional residual capacity is associated with increased response to albuterol and to methacholine in patients with intermittent mild asthma (Class I GINA) Source: Eur Respir J 2004; 24: Suppl. 48, 586s Year: 2004
Sputum eosinophil counts in a large population of mild-to-moderate asthmatics: distribution, relationship with methacholine bronchial responsiveness and influence of a regular treatment with low doses of inhaled corticosteroids Source: Eur Respir J 2001; 18: Suppl. 33, 531s Year: 2001
Prolonged bronchodilation following deep inspiration predicts reversibility to salbutamol in severe asthma Source: Eur Respir J 2005; 26: Suppl. 49, 373s Year: 2005
Time to maximal response to bronchodilators in asthmatic children Source: Eur Respir J 2006; 28: Suppl. 50, 281s Year: 2006
The acute effect of loaded inspirations upon airway resistance in mild to moderate asthmatics Source: Annual Congress 2007 - Advances in respiratory mechanics Year: 2007
Over time effect of montelukast in asthmatic children with exercise-induced bronchoconstriction Source: Eur Respir J 2005; 26: Suppl. 49, 162s Year: 2005
Short-term treatment with sistemic corticosteroids blunted neutrophilic airway response to ozone in mild asthmatics Source: Eur Respir J 2002; 20: Suppl. 38, 569s Year: 2002
Tolerance to the protective effect of salmeterol on allergen challenge in mild untreated asthmatics and in moderate asthmatics on inhaled corticosteroid treatment Source: Eur Respir J 2001; 18: Suppl. 33, 103s Year: 2001
Effects of salbutamol on gas exchange abnormalities and sputum neutrophilia induced by adenosine 5‘-monophosphate (AMP) in mild asthma Source: Eur Respir J 2006; 28: Suppl. 50, 669s Year: 2006